0000105770-24-000084.txt : 20241211 0000105770-24-000084.hdr.sgml : 20241211 20241211161122 ACCESSION NUMBER: 0000105770-24-000084 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20241209 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241211 DATE AS OF CHANGE: 20241211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 241541646 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K 1 wst-20241209.htm 8-K wst-20241209
0000105770false00001057702024-12-092024-12-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) – December 9, 2024
wstlogoq319.jpg
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania
1-8036
23-1210010
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
530 Herman O. West Drive, Exton, PA
19341-1147
(Address of principal executive offices)
(Zip Code)
 Registrant’s telephone number, including area code: 610-594-2900
Not Applicable
(Former name or address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.25 per shareWSTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 9, 2024, West Pharmaceutical Services, Inc. (the "Company") elected Janet Haugen, to its Board of Directors (the "Board") as its newest member. With the addition of Ms. Haugen, the Board increased in size to 12 directors. Ms. Haugen is expected to participate on the Audit Committee of the Board as of the date of her appointment.

Ms. Haugen, 66, is the former Chief Financial Officer of Unisys Corporation, a role she served in for more than 16 years. During her 20-year tenure at Unisys, Ms. Haugen oversaw the company’s business transformation from a mainframe hardware, software and maintenance company to an IT services and software provider. In addition to her core finance responsibilities at the company, she had oversight of Unisys’ corporate development, IT, procurement, facilities and legal functions.

Prior to joining Unisys, Ms. Haugen was a partner at Ernst & Young working with Fortune 500 companies serving global clients in the technology and manufacturing industries.

Ms. Haugen currently serves on the Board of Directors of Bentley Systems, Juniper Networks and CentralSquare Technologies.

Ms. Haugen will be entitled to the customary compensation arrangements for the Company’s non-employee directors, which currently consists of a $100,000 annual retainer and an annual restricted stock unit grant of $220,000. Each element of Ms. Haugen’s compensation will be prorated for her period of service. In addition, she will be eligible to participate in the Company’s Director Deferred Compensation Plan. The Company’s most recent proxy statement, filed with the Securities and Exchange Commission on March 13, 2024, describes these arrangements under the heading “Director Compensation.”

Ms. Haugen will enter into the Company's standard form of indemnification agreement, the form of which was included as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on January 6, 2009.

There were no arrangements or understandings between Ms. Haugen and any other person pursuant to which she was elected as a director, and there are and have been no transactions since the beginning of the Company’s last fiscal year, or currently proposed, between the Company and Ms. Haugen.

Item 7.01 Regulation FD Disclosure.

On December 11, 2024, the Company issued a press release announcing the appointment of Ms. Haugen to the Board. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.

Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit No.
Description
 99.1
West Pharmaceutical Services, Inc. Press Release, dated December 11, 2024
 104
The cover page from the Company’s Current Report on Form 8-K, dated December 9, 2024, formatted in Inline XBRL.



2




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


WEST PHARMACEUTICAL SERVICES, INC.
/s/ Bernard J. Birkett
Bernard J. Birkett
Senior Vice President, Chief Financial Officer
December 11, 2024



3





EXHIBIT INDEX

Exhibit No.
Description
99.1
104
The cover page from the Company’s Current Report on Form 8-K, dated December 9, 2024, formatted in Inline XBRL.

4
 EX-99.1 2 exh99112-2024directorappoi.htm EX-99.1 Document

wstlogoq319.jpg
Exhibit 99.1

Investor Contact:Media Contact:
John Sweeney, CFAMichele Polinsky
Vice President, Investor RelationsVice President, Global Communications
+1 (484) 790-0373+1 (610) 594-3054
John.Sweeney@westpharma.comMichele.Polinsky@westpharma.com
West Elects New Director to the Board

Exton, Pa., December 11, 2024— West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen, as its newest member. With the addition of Ms. Haugen, West's Board has 12 directors.

Ms. Haugen, 66, is the former Chief Financial Officer of Unisys Corporation, a role she served in for more than 16 years. During her 20-year tenure at Unisys, Ms. Haugen oversaw the business transformation from a mainframe hardware, software and maintenance company to an IT services and software provider. In addition to her core finance responsibilities, she had oversight of Unisys’ corporate development, IT, procurement, facilities and legal functions.

Prior to joining Unisys, Ms. Haugen was a partner at Ernst & Young working with Fortune 500 companies serving global clients in the technology and manufacturing industries.

Ms. Haugen currently serves on the Board of Directors of Bentley Systems, Juniper Networks and CentralSquare Technologies.

Ms. Haugen earned her degree in Economics from Rutgers University. In addition, she is a certified director of the National Association of Corporate Directors (NACD).

“We are pleased to welcome Janet Haugen to West’s Board of Directors,” said Paolo Pucci, Lead Independent Director, West. “Janet’s unique combination of technology and finance expertise makes her an invaluable addition to our Board of Directors. With her significant board experience and proven operational track record, Janet will help us continue to enhance the impact of West’s role to deliver healthcare to millions of patients every day.”


About West

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.    

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 EX-101.SCH 3 wst-20241209.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 wst-20241209_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cover [Abstract] Written Communications Written Communications Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security City Area Code City Area Code Document Period End Date Document Period End Date Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 wst-20241209_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 wst-20241209_g1.jpg GRAPHIC begin 644 wst-20241209_g1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_[ 11'5C:WD 0 $ / _]L 0P " M 0$" 0$" @(" @(" @,% P,# P,&! 0#!0<&!P<'!@<'" D+"0@("@@'!PH- M"@H+# P,# <)#@\-# X+# P,_]L 0P$" @(# P,& P,&# @'" P,# P,# P, M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\ M$0@ A %) P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08' M" D*"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2E MIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S M]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 M (! @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC M,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: M P# 0 "$0,1 #\ _?RBD#Y[4*VXT7 6BBD)QVI)I@+12$XHSS3N M%(S[3T MI#)B@!U%-\SVI0V31<+BT44A;!Q2N@%HI V32T[@%%%% !1110 4444 %%%% M !1110 444A.!0 M%('R.>*3?2N ZB@'-%.X!1110 444C-MH 6JT\P#NOZG MITJ26? &.OIZ^U?EO_P5\_X*G^$/&4&M_!7P3\8-.\"W=O?2Z7XQU@:!J&IN M%50KV=M);+L#!BRS,7#*8R@&=Q'H99EM;'5U1HI^;2;LN^AYV9YE1P5%U:K7 MDF[7?;4\>_X+6?\ !9>^^(&NW?PD^#7B&^TC2M&NMNN^*-*NWAGOKF%^+>VD M7D0HZ@NX)\PJ%^[G=^DW_!,K]LRW_;F_8[\*>-Y?L\?B!8O[-\16\/W;;4X, M)/@=DD.)4'/R2J"<@U^ MM^SS\"K&9;>Z_::\L(,?Z#\)M4N$'IAFNTS[_+^ M-?8O_!%#]HWX;?L??M12>#=,^,^H^--!^*#1::+*?P#<:'!;:DI_T:Y\Z6]F MVAE+PL/+!8M%T"YK])S[A_ K*E1P,)>TI:W<)+F_FNVK>:[6L?G>1Y[C?[4= M7&U(\E32RDO=?2R_,_;N,AAD'.:=GFJDMPT,;$L%"Y+$]%QU.:\G\'?MS_#+ MQ[KNEV>D^*&N(-Q^HSK4X64VE<]CHIB.2[=QGBGU!H>'_M:?\%"OA9^Q!=^'X/B1X@DT M-_%"W#Z>%M))_.$'EB0G8#C'FIU]:\C'_!?/]E_.?^$^GYZ?\2FY_P#B*^)O M^#I;5?/^,'P7L0ZYM]'U6X*C[P\R>V4$^W[OCZ&ORR()7[S'\:_6>'.!,#C\ MOIXNM.2E*^UK;^C/R;B+CO&8#,*F$I1BXQMO?LC^B8_\%]/V7Q_S/UQS_P!0 MJY_^(KZ*_9O_ &G?"/[67PLM/&G@;4)-5\.WT\MO!)RC_ "N "AX+_P""7WPDC8DM?Z6^J$=/^/B:2;'_ (^* M\OC+A+!Y3A(5L/*3E*5M;;6;/3X/XLQF:XB=*O%)15]/4^C?BE\3]&^#7P\U MGQ3XBO$T_0M LY+Z^N7&1##&,LV.IXZ =Z^4X_\ @OK^R^R!O^$]N5R,\Z3< M@_\ H%>:?\'(G[1Q^%_[%FF>"K6*VX1X)P^98-XK$RDKMVM;9>J[F/%O&M?+<8L+AHIV2;OY_,_HF/ M_!?/]E_&?^$]G/\ W";G_P"(KVW]DS]N;XH_#G69=:L?#UW'8WTK MVLD CE>,2*HW@9^0@\=,BOY;2#MY=L ^M?MC_P &NOAZ2Q_90^).IN"$U3QK MA#S@^586L9[>M:\5\%8'+,O>+H2DY)I:M=?D9\)<:8S-,>L-6C%1LWHGT^9^ MG7IMPZ!XW*-A@F",J>1P M:]=_;\^/@_9C_8_^(/C=95BO-'T:?[$2VW-S(OEPX/'.]@>/2OY23[DY)KS>"^$J6;0JU<2VHQ:2M;?KO\ (]'C+BRIE,Z=/#I.4KMW M[=/U/Z)_^'^G[,&?^1^G_P#!3<__ !%=%\'O^"S'[/\ \?/BCHO@WPKXMN]5 M\0^(;@6MC:II=POF/M+./CMX MR^+>I1,=/\%6BZ'I#%]G_ /E>78&IB^> M;:6FJU;VZ=SPL@XWS+,L=3PBA&S>NCT77J?MC!)YOMBIJ9%$(R<=Z?7Y%<_6 MTPHHHIC"BBB@ HHHH **** "BBB@ JKJNJPZ1:R37,L4$$*&22:5@B1J.2Q) MX [DU9(]Z^4_P#@M?\ %@?"'_@FC\4;P.B7&L:?'H5OD_>>[F6 C_OEF_*N MG!89XG$0P\=Y-+[V]+^T%X%9?\ D<_"?/\ U%[?_P"+ MI?\ AH'P*/\ F=/"G_@WM_\ XNOY-QI%JJ ?9XN#@?(!0VD6HZP0_P#? K]7 M_P"(60Z8A_\ @/\ P3\F_P"(I3O_ +NO_ O^ ?UJ>'OB_P"%?%FK1V.F>)= MU&\ERT=O;:C#+*X R<*K$G Z_2NFK\*?^#8GX)P>)?VS/&'C*2SB\KP?X:^R MV\FP?)/=S*,@]B(HI!]&K]UJ_/.(LGAEF->$A/FLEK:V_0_1N',VJ9E@EBYP MY;MZ7N%%%%>$>Z%03W #%,9..*)I2J<,!SU/0U^:?_!;C_@L4W[-]E>?"/X7 MWT4GQ%OX0NN:O&X<>%X'7/EIV-W(I& >(U.X_,5%>AE668C,,1'#897;^Y+J MV>=F>:8? 8>6(Q#LE^+Z)>;-K_@LO^V_\4=&TB[^$?P.\%^--6UW48Q#X@\1 MZ7IEQ)'ID+K_ ,>]LZK@SN#\S@_NQG^(_+^1FD_\$WOC]=K'':_!;XCA#\J[ MM$FC5>,XY'':O.-+^*WB[02/L7BSQ1:D;CF+5;A"2QRQR&[G)/O6O;?M6_$S M3@HB^)_CN$( %\0W0"@=!C?TK][R?A_$95AU0PCAKNVG=O[_N/P3.,_H9K7 M=;%J=ELDUI^!ZCI?_!)K]I/5P#%\&_%Z#;G]] D.1]&8?E6#=_\ !/+]H+PY M.D__ J7X@V=Q:,DT4T>F/F%U(96!'<$ _E5#2O^"C'QN\.?/:_&CQU!M.XD MZY(P!QC^(GM7"?$K]IOQ3\8/%LVM>*?'^L:WK-V%CDN+G5F\R0* JC 8#. ! MT[5Z=)9IS-5I4^7R4O\ ,\^:RQ14J,*G,O-?Y']"/@+Q9XT_;M_X)8:Q97^A MWF@_$G4_#D^A:KIFH VCSWR1A)%+$ JEP 1GH!*>V:^5X/@UJGQ#^.7BJ^TW MPW?W=_\ $"[UJTMM _LK^SM2\.F5+*.TEU*8J#)90)%+MA+E8)8;9XU;<#'\ MT?\ ! K]N*3]G/\ ;"_X0SQ#JBUZ?)KUTWLS]CR:=+/, M'#$.34H^[)==.OJT_P"K(CT&UDLM.@AED,TL4:(\IZRD* 6_'%7J9'"(\]3F MGU\3KU/N$K*Q^''_ = :CYW[7/PTL@25M/"$LH&.%,EXPZ^X3]*_-4'+#OZ MFOT$_P"#E35CJ'_!0?1K8DXL?!MF"-V<%[BX;D=NGXXK\^P<5_2W!L.7)J'I M^;9_-7&<^;.*]N]OP*^JEH["8J.^#_ %K^JS]D#P6OPY_9,^&VA)'Y M1TSPS86^S&,,+=,_KFOY:_!^@'Q;XTT/20"6U34;:S^GF3*O]:_JA^-'Q;TG M]F/X"^(_%^L-_P 2CP/HLVH3QJP5ID@BR(USQN<@*N>["OBO%">B1]KX804(XBO+965_O9^&7_!PA^T8OQN_X*!WOAVUG$NE?#+3TT.)0256Z MDQ/M7?%'B_5/B'XHU3Q%KEPMUKOB*^N-6U.11@27 M5Q(9I2!V7>Y '8 #M5 MGL<=*_2,GP,<%@:6%7V4E\^OWL_-\ZQKQN.JXG^9 MO[NGX"D9-?O7_P &W&D'3O\ @F^ERRX-_P"*]5GR?X@'1 ?_ !S%?@IC=T(K M^B/_ ((-Z.-"_P""6GPX.W:U\VH7;#&-V^]FP?RQ7QGB9/ERR$>\U^3/LO#* M%\RG)](_JCPS_@YS_: /A3]G+P1\/;68I<^,]6>_O$5\'[+:*#S[&25/Q6OQ M/0 XQQD_E7VC_P %]OC^OQO_ ."BVOZ7;R^9IOP\LX?#L(!ROG#]]<$>^^0* M1_TSZ\U\7$;5STP*]G@G ?5%[F#R=:O+3^V=9XP?MMU^^D! M_P!P%(Q[1CI7X5_\$H_V85_:W_;R\"^&;FW^T:)I]S_;NL KE/LMJ1)M;V>3 MRT_X$:_H4_:J_:[\!?L7_"V7QA\0=S^&FE:?\ #70 Q$,\H34=6G7LSNP\ MJ(G^ZBMCIN/6OC3XA?MA_%KXM7)G\2_$_P ?:M(6+8DUN=$7)SA51E 'L*\7 M+_#;,:T>:O*-._3=_AI^)[..\25Z=\'/^"B_QU^ 5Y#+X9^*G MC&&*'_EUO;]K^U?ZQS;@?YUVUO"[$J-Z5=-^C7ZLXZ7BCA7*U2A)+U3_ $1_ M4/%-Y@SC']:=O%?G-_P21_X+=)^VIXH3X<_$6PT_PY\0S 9=,O;,E;'Q$$&9 M%"'F&< %MF2K+DJ1C;7Z*&01D<@#.!S7YYF>6XG 8AX;%1Y9+[FNZ9^@Y;F> M'Q]!8C"RO%_>O)^9+YB^M,EG"8P-VXX^M?/_ .WM_P %%_A]_P $^/ *:SXQ MO)KK5=25QH^A6.'O]6=1SM4\)&"0&D?"C<.I(!_'']IO_@X,^/?QWNKB#PU> MV'POT1V*QVVCXN+P(>F^ZD7);&.41![5Z^1\)YAFBYZ$;0_F>B^7?Y'DYUQ9 M@,L]RM*\_P"5;_/L?T&?:'X_=F@W#C_EF37\HWC']HWXC?$:_>[UWXA>.=7G M?EGN=_:%_ M9_OX9-%^)WB#4+6#'^@ZW+_:=JRC^$K+E@#_ ++ ^]?L5_P2@_X+#:3_ ,%$ M([SPOKNEVWA7XE:+9_;9[&&(Y*[E.Y@"ZL]X#SWA%;_P#P7V_X*.?$;]CGQ-\- M?#?PS\1KX?U'6(+W4M4F6WAN'DA4QQPH5D4A1N,ASWVXK\C?VG?VP/B+^V7X MFTO5_B/XA/B'4-$M'L;.4VL4'E1,^]AB-0#EL')S7N<$<)8B=6AFLVO9IMI= M=+I:>OF>'QKQ9AJ=&MED$_:/2_36WZ'FL;?NU)QD\T$Y!]:55V_C01N&!R17 M[OTQWCUK^8 M_P""G_!5;X\?LQ_"BQ\(>"?&_P#8OAS1EE:VM%TRWD*EV,C99E+$EB>I[U_0 M[^Q3J?BG7?V2_AQJ'C?49-6\7:IX>L[[5KIX4A9[B:)96!10 ,;]O']VOY_X MYR7$X?%RQV(E&U23LDW?3Y=C^@^!LZPV(PD<%0B[TXJ[=K7^\]3+ &D9QM/T MICR+$,L< U\>?\%._P#@J7X+_8XTZ7P7#XUL]!^).N67FV,6=F)+$Y)))S6 MG?\ P7^!WC7Q1>ZKXA_:NUC4=6UFZDO+^^E^%6HO-=3R-N:5V>[.22223^%= MSX._8R_9.UR-!?\ [8=[9NPY\SP#-; $=?O.^ >W]:_:\HP.5Y;AE3G"I*37 MO24*BN_E;1'XSFN.S3,L6YPG345\*%D0-^Q1\'90LADRL\,F.,#'FVC<_I]*T?# MG[ '[$=U*!=?MB7G6MZ5?U9=#!YXY>[4HW]:?Z(P?#G_ 71 M^"&D/YK?L:^ [";85+V2Z;D\],_8UX_SBO4M*_X.2O@_'HMUID_P(UVSTZ_C M-M=6]NU@T4T3+M9'4!0PP2-IZBMCPC_P1\_85U95%O\ &"TUQF0$>5\0K$[L M=6_=GI7J'A+_ ((4?LCWJ;[&*YUQ!B;/_"6M,NT_=^XWW3V-?-5\3PQ?^%5^ M^7ZL]ZAAN)MO:TO_ "5_H?DE\4/VQO!NH^,]47P?\"/@YI?AU+V1]&>XTB^7 M4+>WW9A$C1WH42I\IW+C!48 [?NY_P $L?VVX_V\OV0?#WB^[%K!XIT__B3^ M);6 XC@U"$*'=%.2J2J4E0')"R8R2I)^ ?\ @K;_ ,$G_P!G/]F+P3X/\2V? MBO7?A/I=Y=RZ5)_9^@3^)QJUP4,R[OWZ>2P5'P2<-Z9%<'_P1C_:.^&/[&?[ M6;Z!I'QAU[Q3H'Q,,&CSV5YX"?1[<7BL?LMS]H:_D\LC=)&P,1W>8.@ -=F> M4<#FV4JO@(3YX7M=2>BW5W=>>C.;)<1C,JS1T,?.'+/M9:O9V5GY'[H @=Z6 MJ]N[,S \D5+GV%?DEGT/U=RMN?SX_P#!Q%J@U'_@IUK,8*DV?AO2KE?7W_!>35#J7_!4[XB EV%I;Z9;J&Y Q91MQ_P!]U\@DU_3O M"\.7*K?$_5MCJIZV%D4FG)]C(]LF/\ ;/I7 MYT_\$+O!_P#PF?\ P4Z^'H.=NDI=ZB?^V<# ?JU;'_!?/]HMOCM_P4+UK289 MO,TKX=6D?AVU4'&J]1?%5ERK[M?PN?%I8G;@ $UZ+\:?@VOPF^%/PJO9U*ZIXXT2Y\ M1S$\%;=[MX;8$>Z0,W_;2N4^&GPUU+XT?$?0/"&D*S:GXGU"#2[8CJCS.$W? M1023]*^N?^"].B6'@+]MG2?!6DH(M*\!^"M(T2T3 &V-$8K^F/QS7U>)QKCF M%'!QWDI2?HEI^+_ ^7PF O@*V+ELG&*]7_P$?%A8(H89QW_SZU_1Y_P39\4: M?^S]_P $A/AKXDU5A#IGAWP/_;EZ78S,!RL M+L,?[I-?MI_P4Z^*R_LW_P#!![X>^$K5EBO_ !WH^B>&8T7J(3;++>$P.6)!EGD:1@,]@6P!V [5GNN3C.#G&:3!)R2*ZE'-OIMEN>5ESU\R9L8'4QJ* M_.']O3]MWQ-^W_\ M#7WC?Q#YUKIT1>V\/:0TF^/0[(MD1KT'F/M5I' !9@. MRJ!^@?\ P7+\3VO[&/[!_P 'OV:?#MT,7MJDVKRQY4W%M9A$P]+):3LH).=NLGK M^ O;H.:]+_99_8\^(W[9WC>Z\/\ PX\.2Z[>V$(N;V4RK!;6,;'"&65\*I8@ MX').UL @$UYH>!S7[_\ _!O-\"+7X3_\$[M%U\PQ_P!I_$34+K6;F7RMKO$D MK06ZD]P(XMP[?O"1UKT^+L_EE.!]O22?)'&H^F(B:_+4 M#:![UV<-YC7Q^7T\5B%:4KWMZV./B7+J.!S"IAL.[QB]/N-OX7?$N^^"WQ/\ M.>,-,E>VOO"VJ6VJ0R(<%3%(K,/H5W _6OZB_C_^T7H/[/7[.WB#XDZZ6_L3 M0=).J/&K //E 8XE/]YV*J/+M46XOMK8+P6%LIVD?W3-+$?^ "OD..,KACZ_LF_\$V_C+^VWH=YJWP^\)&^T6RE, M#ZC?7<=E:22C[T:/(1O9<\[0<="17%_M*_LL>.OV/OB6?"7Q#T-]#UHVZW<* M"9)HKJ%F91)'(I*LNY2/4$+ MI/B7<^%[30]&.GVL%GI$5]'=*\IE,WFF1<@@J ,<9R$S65#,X> MSHW=G9W?9WZW/T>'!6$Q>5QKY;/GK:-JZMYJW2Q_/KC'4<#UKW/_ ()B>-K[ MX>_\%$/@WJ.GNZ7#>)[>R;:<&2&XW02I]&C=@:_0S_B%=TAAQ\#M334X].?08;=;IT5@H:02L5 M)SP.U=F9<=9-6PE6BIMN46DN5[M>AS97P-G%#&4JLHI*,D]ULF?"'_!P+\9[ M;XC?\%+?$>FI=PF+P;IMEHB RK\KA#-(,?[TO/?BOC!&##I@]37]0'[5G@'X M54P2=H7[Q/2GU]3?\$5?@99_'[_@I'X$TS4[.#4-'T9+O7M0M[B%9 M898[>$A596R&4S2P@@^M?6YCC8X3#3Q4]5!-_B(JA0OX "N3T3]G+X=^%]3M]3T[P)X.T^_M'$MO=6VCV\4T+]F5E0$ M'W!KPK_@J)_P4W\/?\$ZOA*D\:V^N?$#7XG7P_H!D(\TC@W<^WE+>,]3U=B% M'.2/P;/L\K<18FC0PU)IJZ2O>[=M>G8_>L@R2CP]AJM;$U$T[-NW1=/Q-?\ MX*._MG^)_P!F+X3FU^'/@7Q!\0/B-KR/'I5EIEA)=0Z<,8^UW10'"*2-J=7/ M'0$C\*_%/[!'[47QK\=:OXEUOX5?%#6?$/B"\-UJ-]?:5(LEU._5RS8PH & M/E5551@ >0_%'XU^+OC)\2=8\7^)M?U6_\ $'B"Z:\O;O[0\.]R>%15("(H MX51PH ':LW3?BWX@T )]D\7>(;(HQ*F/69X]I/4C#]Z_3.'^%ZV4T;4)0]I+ MXFTV_16DM#\US_B>CFM;]]&?)'9)I?-Z/4][T_\ X) _M-ZG'NC^#GBE5.?] M:8(CQ[,X-='HO_!#C]J+6HMP^&LEI\H.+G5+:,\]OOGIWKY_L?VOOB-I40CM MOBKXY@10%"IXEN< #H/]972Z+_P4@^-^A/\ Z%\:?'\7(?\ Y#,L@R.!P2>* M]>LLZM[E2E]TO\V>5163;3I5?O7_ ,B>^V7_ ;Z?M0WDRA_"WAJV5VP6E\1 M0?+[D#)(KI-'_P"#;C]HO4U4W$_PYTTL&)\[69&*D'@?)">HYZ\9KQ/PY_P4 MV_:FGD#Z;\3_ (G:B0, )&]POS=./+.?:O2_"W_!2W]N654CL-1^)FHJPV*S M^"S/NVCGDV^,XZG->-B)<1I>[6H_<_U/8P\.'F[NA69WEC_P; _&N_F(O?%G MPG@4XRPFNYB?7(^SCI]:Z'3?^#4;Q;>LOV_XH_#VV4,<>5X8FNL#UYE3G/T^ MM8W@O_@H!_P41G*O;>&O&NKHW[Q1<^ P.._\"\?K7I'A_P#;G_X*1:@JQQ?" M%97#!/,N/" B/.2.LZC KPL5BN(T[?6:/WQ7YGT&#H9!NL/5^Z7Z,\Y_:%_X M-I/'_P "?@U>ZYX2\9Q_$?7K>>%8_#NE>'#8MP20XFCEAL=[1%3D,"I/S X/'/>OKG_ (*"_M>?MH:A M^QWKVG?&/X=:'X+\'ZO=6=G)K5HQL+V*=9UEC6,+<,3O:+!&,;2:_-F3Q/J. MJ,7DU?5;J1V+$M?RR9)')Y;O7T7#L\WK4).O6IRUZ+F_&+2_4^:XBAE5&NO8 M4JD=+ZZ?@TW^)_35_P $XOCGXF^.G[*'AC4/&_A_5_#?CG2[==+UZSU* PS/ MY?VB?[B_\ ??\ ]:OY\_\ @@[^VBW[+'[:5IX= MU>\=?"/Q15-#NO.D.RTOMV;.?GIEBT)'_38'^&OZ"O+G]!^M?C_%F2RRS'RI MOX9>\K;:[KKL]#]\?\%2-5&M_\%)OC?<(Q9?\ A+;B$'&,>6D?B?\3-2C#V'P MW\ WFIN2VWYVD147IU;!%?%GB7Q7?>._$NIZ]JG?"OXK?\*Q_8\^+&F6TY74?B)JNC:$T:D K9V_VF\G)]F98E_$UY&,JGTX% M8X+!VQM?%2WERQ7HE_FV:8_%_P"Q4,+':-Y/U;_R2/O7_@W8_9Z_X6_^W@_B MF[A633_AMI;ZEN8$@74Y,,'XX\QO^ UYS_P7%\3GQ-_P5$^)O)9=/DL[$<\? M);1D_D6_G7Z;_P#!N/\ L[CX4?L-R^+[B'9J/Q*U5[\,5PWV2 M# /<9$K#_ M 'Z_(G_@I;XE/B[_ (*#_&6^)W#_ (2R]@4YR"(G\L?HM?)Y1C?KW$^(J)W5 M./*OO5_QN?69Q@OJ7#6'IM:U)V&#T^;'WC7PWX"T^#6 M?B+X>M;EQ%;76JVL-79C'X@UN>6W&2 M<6ZL8X5SZ"-5%?5XK ^VS*A6DM*:E]\K)?A<^5P>-]CEM:A'>HXKY*[?XV/. M6('I@5]S?\&]O[+?_"_OV\HO$][!YNB?"BS&M3%ERCWTVZ&RC/H7O_J!Q MD@CX9+!3@G ZDYZ"OW]_X(!?LV1_LY?\$^[#Q/J5N+?5OB/,WBB[/QUFCPF5RC!^]4]U?/?\/S/7X$RSZUF<9R7NT_>?RV_$_, M#_@NK\:C\9/^"E'C2%)O-L_!T4'A^ 9R%,2;Y&,)&@9H2QPJ@9)).,D\UY3^S3^SYKG[57QX\.?#[PV]I'K/B M6X:""2Z++!#M1G9W*@G: IZ U]Q-_P &R?QS3=_Q5WPV"D_\_-U_\9KS<[Q^ M3TY1HYFXWW2DK^5]CT\DP&<2A*MEBE;9N+L?#W[0?[1WCG]JSQ\OB?XA>(+C MQ-KJ6J62W4L,<)6%"Q5 L:JH +,>G>N)"E>M?HJW_!LM\14H*G2K145LE>WY&]?A7/*LW4 MJTI.3W;_ .'/C;]BGX:'XR?MB_"_POL+IK'B>P253WC282O_ ..HU?I;_P ' M3GP_U&YT?X,>+HXV?2=/N]4T:XDVG]U/<);RQ GMN%M*![BM7_@F?_P0G^(G M[(O[8WASXA^-?$'@S4M(\.P7,D4&FR32SR7$D9C0X>-0% 9B3G.0.*_2?]H/ M]GOPI^T]\(M8\#^,])BU;P]KD7E7$).UT8'*2HPY61&^96'0U\%Q!Q;AXYUA M\7AWSPIIWM_>W_"Q]]D'"F(>2U\)B(\DYOKY;?B?REF:47>J>!8+GXI>#HBTDJZ'Y3F63 MXO!3=/$0:?X?)[,C,6X,K %6QD8X/M7KG[,W[=7Q?_8[N$_X5[X[UG0K%7$C M:6\GVK39.<\V\NY!GU4*?>O)FE"_Q+FEQGTXKJQ&%HXB#IUXJ47T:N''6#]EE"J/[;;_ $7Y M'QOB-C/:YJZ2^PDOU?YC7.,FOU._X-=/A-_:/Q9^+7CV:(;-(TJST"V?I7[V_P#!MY\)U\#_ /!/0Z])"JS^-?$-YJ!. M.6CB*VR9_P"_+?@16GB%C/891**WFTOU?X(S\/<'[;-XS>T$W^A]_3MBU!ZD M8S7X3_\ !:;7-9_9H_;[U^[\1?#WX7>.-/\ &$,6LZ+J?B+1+FZN#;*HB:UW M"Z"[87!&%4#]XAV@GG]W'0%"*^0O^"R7["6G?MM?LJ2H;EM*\1> I7U_2=0A MT\WLZHL;"ZMEB#(SB:+HH89DCB/.VOQ[A3,:.#S"#KJ\)>Z]6K7M9Z:_\ _8 M>*86X/;^M>A^#O\ @GM^ MP!J1C>7]I>^O5;,@\_58;/Q:9_P=,>!7VB\^$GCJ#@$BWU&SFY[]2G'OWKI=(_X.>/@S=?\?O@W MXEV(+;21;VTN!@<\2UPFC?\ !,/_ ()\7<4:CXT:;=L H_>?$"TC8D]#MXP3 M7IW@G_@D?^PSJ6T6&K:%KI=MB_\ %JOO7YL]Z MC6XEDTG7I?A^A?TW_@Y2_9YO''FVWQ&M,C.9-%#C/IE9#U]JZC2?^#AK]F2^ M0>9XE\0V?R@_O]"N.I[?*#R.]7M$_P""+O[(KR)<6W@?0[X+DC.OSS(P/?'F MD'^E=UH?_!(7]F;2;=5M_@QX'GV)M!FMC<'')!)9CR?7WKQ*\^'$O]U0G4M*\6Z5< M?9+&)(G*3JC* 9#(0J\]"U? 'C7_ (*4Z=XO$S_\,V_LTV?F!,LOAB5P"O'_ M #V /IBO;_\ @I3\,_V0M7_:1U+1M!\?R_"[_A$';1;_ $;PS\/_ +9;/=1L M?-D:<31B1@?EZ?+MQ7F7[(7_ 3,\&_MV_%]O"WPW^*?B[48M.B-UK&IW7@+ M[+::7#NPFZ4WA >3#"-,$DACC:K&OT+)L+DV$P/MJD)Q6[ECX#.,7 MF^+QWL:52$GLN6WZW9TO[ 7PA\0?\%,OC(^@Z5\(/@;X6\)Z.Z3^(O$-EX6G MC;2HB[ &>_G('F7,S?QRN1DD_08 KT'^S8_[B?K7YAQ!G:S M#$7HKEIQTBM7\W=[L_3,BR5X+#J-=\U1[O1?+1=#^6+]MG5FUW]MKXS73;MS M^/-<3EMQ/EW\\77_ ( /ITKS,Y,?O7:?M+7L>K?M0?%&]B*F&\\<^(+E&7." MLFJW3C'X'O7&+T]*_H[+8N.$I1>EHQ_(_G3-K?7:MG=$M!1'UOQ3J5OHVG[P=BSW$JQ(S8YVJ6W-C^%6/:LL@XR*^[O\ M@W:_9V_X7/\ M^)XIN8A)I?PNTJ35I&9,J;RX+6]JOLWO7U%6N9<&6Y)F?!_B8[ MC^IK\Q\+8.57$UI:OW5][9^E^*$HQHX>C%66OZ#G!(XZC\#2*<)BG#GZXI&& M?J3U-?L*1^/7Z'H/[*?[/%W^UA^TCX-^'5H' \5ZE':73J.8;4'=YK&OF]/#7]VE:_JVF_PL?NO M65O#Y3/$-:U+_Y^@7_!MS\*AXW_;VU3Q M#(B/%X*\-3W*[OX9;B1(4Q^'F5^N7_!2?]J&[_9 _8D\>>/M->T36M*LEAT@ MSH'B:\F=8H%/#OA_ M4/"G@+0[TZE)%?7"2WFL7(7;&\BI\L:1AGVH&;);<3P /RK/^&L9F/$$:DX? MN%R^\]K+5KYO0_5LAXCP67B(H9V/8*:^RJ\-9+2@ZD\/!))O;HCXJCQ)G- M6HJ=.O-MNRU/W-_8,_X*'?$36/\ @F+XX_:!^+BZ=KIT:XO;K2[/3[9--%Q: MVX6/9N^8;GFWC>0<>G%>$K_P=561C!_X43J(X_Z&Z+_Y%KZ8_P""AOP%T_\ M9S_X(G^-O 'AY7?3O"'A2"RC8+AIO+DC,DA'JS;F/N37\].X'N3D]:^#X7R# M*LX^L8FI3LN=J*3:2C96T1][Q1Q!FF4+#X:E4UY$Y-I.[OKN?KX__!U)8,0? M^%%ZEN'3'B^+_P"1:^E/@)X?^$O_ 7&_9FC\?\ Q!^#FG:3+/?W.G6DSWBS MZDBPD+YJ7<4<3@$D@*<@;:_GQ;CD'&*_1'_@E)_P6_T;]A#X"W'P]\9^#=&M4\->)+O7/ M!_C2YN;:UM=0C OM,FA192C2+A9HRA.'VJP*X.<@U\7#&*^EO^"G_P#P4GUK M_@I)\7=-U2?1V\,^%O#$$EMH>DFZ^T2(9&4RW$S!0IE<*HPHP@4#)Y)^:1G! M(&1WK[;AZ&.C@*:S%WJ]=ODG;JEN?$\23P,\=-YOZC_A7\-=,^#WPY\/>$]%B M-OH_AK3[?2[*,]1##&$7/OA!B_>;YFO);?>S[OPRRR?MJ MF-DO=2Y5ZO<_ S_@X%^*_P#PLW_@I9XDLD(S"K6;WD_N(=0N&MK"65%[".;< "96@5Y.G^VS=P] M*^Y/V _^"E/[27Q&^.'PG^$.F_$B]_L&]UBPTG;+8P2S1V,;J9$,Q7?CR8V7 M/7'>OF>.\DKX_"PE2DE&G>4K^GIZGU' >=X? 8B4:L6Y5+15O4_H- X/O4,T M1=PP)_\ K>E2J<]N#2L@*_2OY^UW/WZVA_/A_P %4/\ @E1X[^$'[:7B%?AO MX!\5^*?!WBQGU_31HNE37D>G-*Y,]LWE@A-DI)4'^%U]*\6T7_@EW^T?KP'V M;X*>/\$JO[W3Q",GH?WA7CU)Z5^V/_!:[]AB/]M3]C'45L+&.Y\8>!7?7M"; M;^\D*(1/;@]<2Q9&.[(GI7\[^F^(-2TU4-KJ>M6H7!"PW]Q%C XX##I^E?OG M".<8S,70_!^+,GP>7Y@W4A+DGJN5I>JU3ZGT99_\ M$4,/AW96I90_^F:Y9 MQ'D=#\Y^:OF73/V@?&_AUU:S\?\ C2Q93O4Q>(;E,$]3_K*W],_;N^+GA\ 6 MWQE\?P #R\#Q+._R]3U<]\5[M6EG;5X5:?\ X#+_ .29XM&>2_:HU/\ P)?_ M ")],Z?_ ,&[/[3FHW 6X\/>#;-2V"\_B*%P!ZX16./UKHM+_P"#8WX\ZQ$K M7.H_".P.#\MQJ=TY0YZ'9:,/?\:^;='_ ."J/[06E'%G\;_'9QC ;4/.QCZ@ MUU_AC_@KO^U-&4^Q?%/QCJ+;R%$EBEP7)'W<>5ZXR8H^/?]!5/]HS_ M (-]?BG^S%\'+KQ/X?\ B#JWC_6HKF*WMO#WA7P[>)<7&[K(TQO<11QJ&)/E MOR% &6 'FTW_ 6H_:]\':7;SZAXMU*TM9\QP7&H^&(8TG8HWFO>)KNSCM))$1K;3=$L$;$D[QH=J1AV)8]7=@!G@# MBIX?/XOV^.Q%-4HZMJ*=TNG3?U.R>+R.2]A@\/4=66B5W?7YL/@7_P $G/CU M\=_C5IW@^;P!XJ\'_P!H2&2^US7=-EBL=,AR#),\C8$C_,-L8;=(QQP-S+_0 M/^QQ^QQX-_8C^!VE>!_!=K)'8V@\^]O)\-=ZM=E0)+J=AUD;:.G"@!5 4 5D M?L#?L%^"?^"?_P %H/"/A.S2:[F"3:SK4L*I>:Y=!<&:4C) '(1,D(O [D^Y MJ@4 <"OS?BCBG$9I4]ES?NH[65K^=KOY=C]$X7X7H993]JU^]ENWK;R3T^8 MHZ4445\D?7'\B?BKQA;>)?&&KZHUU$6U/4+F])>1=S>;,\F3[_-_.J7]L6@_ MY>K?_OXO^-?U>G]EWX99S_PKOP)_X(+3_P"-TI_9>^&?;X>>!?\ P06G_P ; MK]?CXI4XI)8=Z?WO^ ?D,_"Z4Y.4L1J_[O\ P3^3]]8M>UU;CW\Q>/UK]Z_^ M#D]Z^T_^&7_ (9C MI\._ F?^P!:?_&ZZ_0O#]CX:TFWL--L[33["SC$5O;6T*Q10(.BHB@*JCT Q M7S_$W'+S7"?5(4^1-IO6][=-EU/?X:X'CE6*^LRJ<[M9:6MY[GF7[=7BC_A# M/V-/BIJHF2!K+PKJ+K([;50_9W R?J:_E;L=6M$LHE^U6X^0<>8.3CZ]*_KT MUC1K37],GLKZTMKVSN4,]?U@']E[X9C_ )IWX$_\$%I_\12Q M?LQ_#6&0.GP]\#(P(8,N@VH((.<_ZOZ5]9_Q%2%O]W?_ (%_P#Y->%EG?ZQ_ MY+_P3R__ ()8_LJM^QU^Q!X'\'7<#0:Z]H-4UL,NUQ?7 $DJ$>J;ECY_N=37 MT-(9Y-3U.RT^$RW'ARX0K!LIYK])R'Q'GAZ,*+A'$=Q< U^['_!*'_@D1H'_ M 3PT:YU[6;^V\5?%+7;86]]JL<16VTVW)#&TLPW(CW ;Y& :0J#A0 H^P_# M/A?3O".C0:=I6GV.E:?:C;#:V<"P0PCKA44!1^ K16,* ,#@8&!BO@N(N-\7 MFD'0@O9TWNEJWZO]#[WAW@K"99)5I/GJ=^B]$<[\4?A?I7Q=^'.O>%=;C:;1 M_$>GS:;>1K@,T4J%&P3GG!XZ\XK^9K]NC]@CQW_P3]^*-QH?B[3[F709;AXM M$\2)"18:U%DE"LG*K-LQOB8[@+LN+2\MUG@G'7#(P*D9]0:X>&>*:^3U&X1YH2W7ZKS.SB7ABAF].*D^6<= MG^GH?R0Q.)$R"#]*>,["/TK^D/Q]_P $6_V9_B%J!N+KX3Z'8REBQ.ERRV"N M3R25B<#]*Y:/_@@%^S$+TS'P'>NI)/E-K=UY?Y;\_K7Z93\3\N:]ZG-/T3_4 M_-9^&.8(5M/AYX5O- M3L5D\NYUFXS;:19=,F2Y8%20#G:FYO\ 9K]__A3_ ,$BOV=/@[>17>D?";PQ M-=P2>;'/J43:@Z-ZCSBP_2OHO2M,ATJSAM+:"*VM+>,1PPQ($CB1> JJ. , M8 XP*\G,?%&\7' TM>\G^B_S/6R[POM)2QM6Z[17ZO\ R/EO_@F!_P $M?"O M_!.+P#,8+O\ X27Q_P"(8D77-?>'RU< [A;6RF.:F1 #G\*5D#8X'%?E>+QE;%5I5\1+FE+=GZIA<'1PU*-"A'EBNB/Y8_VX M_P!G#Q%^R'^U)XP\'^)K*YLW35[NYTJZFC,<6K64DSO#/$2,,"C*&QG:P(., M5Y4&&.H./>OZR?B-\*/#7Q?\/G2?%?AW1?$NFD[A:ZI91740.,;@K@[6P>HY MYKQL_P#!)S]FZ4[G^"G@$$\X&G!1^AK]6P'B?3A1C3Q-%N25KIJS^_8_*LR\ M,IU:\JF&K)1;O9IZ?XYK[I_X-SOABGQ$_X*/1:RQ1X/ GAN]U8G(. MV:4I:1 _59IC]4K]>5_X)-_LW(Y(^"?@#/JVG!OYFO3?A#^S/X ^ (N%\$>" M?#/A3[8BQ7#:9I\=N\Z*255V498 DD ^IKGSOQ$H8S!5,+1I2BYJUVUI]QOD MGAW5P>-IXJM5C)1=[*_ZG?1_=7Z5)4^\&^-XVUW0KK4_!$%S/DL!=6S2%OG:.8ALX!V3 M1_4_O1(,FOEC_@KG^P_IG[G MS7S1^*'@G_@IYJO@O:1\%OV;[]EYW3>!(XR7[-\DHY[8Z>U>DZ/_ ,%U?$N@ M!#;_ #_ &;8$3IY/AF>-N>N#YW&?T]Z\+\.?#3]G/5;2.6_^+WQ*LG:,,Z+ MX!B8!CU /VO/'N*]"\-_ G]CB=P=1^/'Q1C!==[]?7]*_9\3A, MIEK4P\WZ*;_)GXUA,7FL7RTZ\%ZN'ZH][\%?\')VL>&6'VC]GOX8S(G!&G:G M)IYVX^5>;:7'ZCZ5VD7_ =/ZE':S"/]GK2K:8QDQ2)XY,BB4# +)_9J';ZX M;/;CK7R=XE^!7['=L?\ B7?'KXGN-S8'_"%K+@=N3(G_ -?VK'^''[)OP=^/ M/Q-T?P9X ^)/Q/\ $OBCQ"_DV-K_ ,('%&K, 2[NWVOY(T0%F;& I#/<]@U2A6@V^BY6_E8[ZR_;M^._P#P5(_:"T#PI)X! M^#OC[Q/>22KIL.J^$$NK?1;9FW2.\KLS1V\8(W2$%CA>K, ?VQ_8F_8F\*_L M:_"Z+3-&TWPZGB/4HHG\1:QI6C1:6FM7* _.($+"*)2S"./2C'HK^\^[7Y+YGZ5PYDU?#T_K&/ESUI=[:>2_5@ M@Q]32T45\J?5!1110 W91LIU% ";!1M&,4M% ";,_2C8*6B@!-@HVBEHH .E M-\O/7FG44 (!BC9S2T46%80( *-HQBEHI)6V&-,?''%+LXZFEHI@%(1D4M%* MP";!2@8HHI@)L&:-N*6B@ HHHH ;Y?3GI0(^:=10 FP4%.:6B@! ,4M%% !B MHGM@7W D$>E2TC=#0!^!G_!5O_@D=\0/!/[:6NZC\+O OB'Q/X1\=RR:[;C2 M;/S(=*N97+7%LQ!VJ/-)=>0-KX XKPBT_P""2W[3-_;K+%\&/&!4]-QM8V_$ M-,"/RK]KO^"RO[!%I^W=^QMJNF0Z78ZAXR\)DZWX=DFMDED,\:GS+=2P) FC MW+@?Q;#VK^<_P-\/KKQKXFTS0?#VCW%]K>MW26EE86L9$US.YVK&%'\6Y]QPGPE0P*6+J1:J- M:)N_+\[+4580K9R?I3Z**^%/NPHHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@""Y'S)VPW6ODK]D+_@GG\,O@/\ M@?&?XG:)I4S^*-6UQH[=KEDD@T5+B"* MXN%M$"#RO-DE8L26;&%!5/EHHKTLNJSC1KQBVDXJ_G[RW/+QU.$JM%R2;3=O B+3H?6T4(B<8STJ53D445YAZG86BBBF 4444 %%%% '__V0$! end GRAPHIC 7 wstlogoq319.jpg GRAPHIC begin 644 wstlogoq319.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover Page
Dec. 09, 2024
Cover [Abstract]  
Entity Central Index Key 0000105770
Document Type 8-K
Document Period End Date Dec. 09, 2024
Entity Registrant Name WEST PHARMACEUTICAL SERVICES, INC.
Entity Incorporation, State or Country Code PA
Entity File Number 1-8036
Entity Tax Identification Number 23-1210010
Entity Address, Address Line One 530 Herman O. West Drive
Entity Address, City or Town Exton
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19341-1147
City Area Code 610
Local Phone Number 594-2900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.25 per share
Trading Symbol WST
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.westpharma.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports wst-20241209.htm wst-20241209.xsd wst-20241209_lab.xml wst-20241209_pre.xml wst-20241209_g1.jpg http://xbrl.sec.gov/dei/2024 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "wst-20241209.htm": { "nsprefix": "wst", "nsuri": "http://www.westpharma.com/20241209", "dts": { "inline": { "local": [ "wst-20241209.htm" ] }, "schema": { "local": [ "wst-20241209.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd" ] }, "labelLink": { "local": [ "wst-20241209_lab.xml" ] }, "presentationLink": { "local": [ "wst-20241209_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://www.westpharma.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "wst-20241209.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "wst-20241209.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0000105770-24-000084-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000105770-24-000084-xbrl.zip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wst-20241209_htm.xml IDEA: XBRL DOCUMENT 0000105770 2024-12-09 2024-12-09 0000105770 false 8-K 2024-12-09 WEST PHARMACEUTICAL SERVICES, INC. PA 1-8036 23-1210010 530 Herman O. West Drive Exton PA 19341-1147 610 594-2900 false false false false Common Stock, par value $0.25 per share WST NYSE false